DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nacolomab tafenatox
Nacolomab tafenatox
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
Ep 2505209 A1
EP3027208T3.Pdf
INN Working Document 05.179 Update 2011
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
(INN) for Biological and Biotechnological Substances
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
(12) United States Patent (10) Patent No.: US 8,784.808 B2
Customs Tariff - Schedule
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Harmonized Tariff Schedule of the United States (2006) (Rev
Top View
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Engineered Fc Regions for Site-Specific Conjugation
Tłumaczenie Patentu Europejskiego (19) Pl (11) Pl/Ep 3129406 Polska
WO 2018/151820 Al 23 August 2018 (23.08.2018) W !P O PCT
(INN) for Biological and Biotechnological Substances
WO 2018/231759 Al 20 December 2018 (20.12.2018) W !P O PCT
Dihydropyrrolidino-Pyrimidines As Kinase Inhibitors Dihydropyrrolidinpyrimidine Als Kinaseinhibitoren Dihydropyrrolidinopyrimidines Comme Inhibiteurs De Kinase
Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin
Ep 3088005 A1